02 9541 3500
Characterising Lipid Nanoparticles for Vaccine Development
Lipid nanoparticles (LNPs) either loaded with nucleic acids or as liposomes containing an aqueous core,
Engineering Vaccine Delivery: Fundamentals Of Creating Lipid Nanoparticles And Liposomes For Encapsulating Therapeutic Drug Molecules.
The terms Liposome and Lipid Nano Particle (LNP) are coined interchangeably. Whilst they are quite similar,
How Extracellular Vesicles and Nanoparticles are Transforming Drug Delivery
When I reflect on how medicine has evolved over my lifetime, the shift is remarkable: from a scatter-gun
Precision Engineering nanoparticles for drug delivery
“This is where formulations come to die!” These are words of a prominent pharmaceutical company GMP
WHITEPAPER: A Better Way to Create Nanoparticles for in vivo Treatments.
By Peter Davis The production of technologies, like most things, is not immune to imperfection, and sure
Effects of Polymeric and Lipid Nanoparticle Self Amplifying RNA Formulation on Protein Expression and Vaccine Immunology, presented by Dr. Anna Blakney
You may be asking, who is Dr Anna Blakney?Dr Anna Blakney, Assistant Professor at The University of British
Exosome Isolation: Purification and Characterisation Tools
WHAT ARE EXOSOMES? Exosomes are a type of extracellular vesicle (EV) typically 30-150nm in diameter
UNSW RNA Institute making next generation RNA therapeutics and vaccines using Micropore Pathfinder
We are excited to share the news – Micropore Technologies Ltd Pathfinder PRO 250 is ready at the UNSW
The Key Considerations For Developing Lnps As Drug Delivery Vehicles.
Lipid Nanoparticles (LNPs) continue to grow in popularity as they enable the efficient delivery of therapeutic